A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
Deciphera Pharmaceuticals, LLC
Deciphera Pharmaceuticals, LLC
Kivu Bioscience Inc.
Amgen
EMD Serono
Verismo Therapeutics
Merck Sharp & Dohme LLC
Ascentage Pharma Group Inc.
Parabilis Medicines, Inc.
Bayer
Tango Therapeutics, Inc.
STORM Therapeutics LTD
SpringWorks Therapeutics, Inc.
Turning Point Therapeutics, Inc.
GlaxoSmithKline
AstraZeneca
Inhibrx Biosciences, Inc
Ratio Therapeutics, Inc.
Kura Oncology, Inc.
Novartis
QBiotics Group Limited
PharmaMar
Zai Lab (Hong Kong), Ltd.
ModeX Therapeutics, An OPKO Health Company
ViroMissile, Inc.
Poseida Therapeutics, Inc.
Advenchen Laboratories, LLC
Pierre Fabre Medicament
Takara Bio Inc.
SEED Therapeutics, Inc.
Angiex, Inc.
LTZ Therapeutics, Inc.
USWM, LLC (dba US WorldMeds)
Lantheus Medical Imaging
Ricoh USA, Inc.
MacroGenics
Deciphera Pharmaceuticals, LLC
Kura Oncology, Inc.
Avacta Life Sciences Ltd
Jazz Pharmaceuticals
Haihe Biopharma Co., Ltd.
Adcendo ApS
Solve Therapeutics
Adela, Inc
Perspective Therapeutics
Telix Pharmaceuticals (Innovations) Pty Limited
Immatics US, Inc.
Miltenyi Biomedicine GmbH
Var2 Pharmaceuticals
Jazz Pharmaceuticals
ITM Solucin GmbH